French Glendon E. III 4
4 · Pulmonx Corp · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Pulmonx (LUNG) CEO Glendon French Sells Shares
What Happened Glendon E. French III, President & CEO and a director of Pulmonx (LUNG), reported three dispositions totaling 56,149 shares for aggregate proceeds of about $86,874. Transactions: 4,171 shares on 2026-06-01 at $1.54 ($6,423), 38,467 shares on 2026-06-01 at $1.54 ($59,239), and 13,511 shares on 2026-06-02 at $1.57 ($21,212). The filing indicates these sales were made to cover tax withholding obligations related to vested Restricted Stock Units (RSUs).
Key Details
- Transaction dates/prices: 2026-06-01 — 4,171 & 38,467 shares at $1.54; 2026-06-02 — 13,511 shares at $1.57.
- Total shares sold: 56,149; total proceeds: ~$86,874.
- Purpose: Footnote (F1) states the shares were sold to cover tax withholding for RSU vesting.
- Related grants: filing cites RSU grants with vesting schedules (notes F2 — grant tied to Dec 1, 2025; F3 — grant tied to Jun 2, 2025; and RSUs granted Mar 1, 2023 as referenced in F1).
- Shares held by trust: some shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust (footnote F4).
- Shares owned after transaction: not specified in the provided summary; see the Form 4 for post-transaction holdings.
- Filing timeliness: Form filed 2026-06-03 for transactions on 2026-06-01 and 06-02 — appears timely under standard two-business-day reporting.
Context These sales are reported as tax-withholding dispositions related to RSU vesting (common for equity-compensated executives) and therefore are routine and not necessarily a directional signal about the CEO’s view of the company. For full details, including post-transaction holdings and original Form 4 text, consult the SEC filing (Accession No. 0001805624-26-000002).
Insider Transaction Report
- Sale
Common Stock
[F1]2026-06-01$1.54/sh−4,171$6,423→ 1,230,140 total - Sale
Common Stock
[F2]2026-06-01$1.54/sh−38,467$59,239→ 1,191,673 total - Sale
Common Stock
[F3]2026-06-02$1.57/sh−13,511$21,212→ 1,178,162 total
- 918,198(indirect: By Trust)
Common Stock
[F4]
Footnotes (4)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.
- [F2]Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
- [F3]Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of June 2, 2025.
- [F4]The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.